RUNX1 can be a master transcription variable that regulates the expression of various genes necessary for hematopoiesis. Studies implied the RUNX1 - "Our study uncovered the very important job on the KLF16/MYC regulatory axis in modulating tumor growth and chemotherapy sensitivity in BLCA, suggesting that combining bromodomain inhibitors, for instance https://clinical-trial-recruitmen57801.livebloggs.com/38353987/top-brd4-inhibition-by-abbv-744-in-cancer-research-studies-secrets